ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Environment

Genzyme And Syngenta Plan R&D For Beijing

April 28, 2008 | APPEARED IN VOLUME 86, ISSUE 17

Genzyme will spend about $90 million to build a 350-person research center in Beijing's Zhongguancun Life Science Park. Expected to open in 2010, the facility will conduct research in orthopedics, transplant and immune disease, oncology, endocrinology, and cardiovascular disease. Today, the Cambridge, Mass.-based company employs 25 people in China and has only one other foreign R&D center in Cambridge, England. Syngenta, meanwhile, will invest $65 million over five years in a biotech research center in the Zhongguancun park. By 2010, the center will employ nearly 200 researchers studying yield improvement, drought resistance, disease control, and biofuels conversion for crops such as corn and soy.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment